x

Search for a research project

* (*) mandatory field

61 Result(s)

Sort by

Funded by an IRDiRC member =

Research projects

GERMANY

Bayern
MARTINSRIED

Cellular Toxicity of Polyglutamine Proteins in Neurodegenerative Disease
Max-Planck-Institut für Biochemie
Abteilung zelluläre Biochemie

PORTUGAL

NORTE
PORTO

CACNA1A gene involvement in cognition and synaptic function in calcium channel disease.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

Search for disease modifiers in spinocerebellar ataxias: human and animal-based approaches.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

UNITED KINGDOM

Greater London
LONDON

Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
National Hospital for Neurology and Neurosurgery
Sobell Department of Motor Neuroscience and Movement Disorders

UNITED KINGDOM

Greater London
LONDON

Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

FRANCE

ILE-DE-FRANCE
PARIS

Funded by an IRDiRC memberSPATAX-QUEST: Identification of new causative genes in spinocerebellar degenerations by combination of whole genome scan, next-generation sequencing and biological validation in vitro and in vivo
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

GERMANY

Schleswig-Holstein
LÜBECK

Phenotypic spectrum and molecular characterization of Movement disorders
Universität Lübeck
Institut für Neurogenetik

ITALY

LAZIO
ROMA

SPATAX: European network for hereditary spinocerebellar degenerative disorders
Fondazione EBRI
Istituto di Neurobiologia e Medicina Molecolare

ITALY

PIEMONTE
TORINO

Identification of the gene responsible for a novel form of autosomal dominant spinocerebellar ataxia
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Genetica Medica

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Centro de Genética Preditiva e Preventiva

PORTUGAL

NORTE
PORTO

Clinical implications of genetic factors causing neurodegenerative diseases characterized by movement or cognitive dysfunction.
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

Mapping and identification of new disease genes in autosomal dominant spinocerebellar ataxias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
PORTO

SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Instituto de Biologia Molecular e Celular
Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas

PORTUGAL

NORTE
SANTA MARIA DA FEIRA

UNITED KINGDOM

Berkshire
READING

UNITED KINGDOM

Greater London
LONDON

Endogenous Cerebellar Human Stem Cells and their Potential Neuroregenerative Role in Inherited Ataxias
Barts and The London School of Medicine and Dentistry
Centre for Neuroscience and Trauma

UNITED KINGDOM

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
Great Ormond Street Hospital for Children, NHS Foundation Trust
Department of Chemical Pathology

UNITED KINGDOM

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
National Hospital for Neurology and Neurosurgery
Department of Molecular Neuroscience

UNITED KINGDOM

Greater London
LONDON

Coenzyme Q10 a potential therapeutic target for ataxia: Evaluation of therapeutic strategies
UCL Institute of Child Health, University College London
Metabolic Unit

UNITED KINGDOM

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
PMARC - The University of Edinburgh
Perception-Movement-Action Research Consortium

UNITED KINGDOM

Lothian
EDINBURGH

Developing non-invasive therapeutic technology to improve motor coordination in cerebellar ataxias
School of Informatics, The University of Edinburgh
Human Communication Research Centre

UNITED KINGDOM

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Henry Wellcome Building for Molecular Physiology
BRC Genetics and Pathology Theme

UNITED KINGDOM

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
Le Gros Clark Building - University of Oxford
MRC Functional Genetics Unit

UNITED KINGDOM

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
The Churchill Hospital
Molecular Genetics Laboratory

UNITED KINGDOM

Oxfordshire
OXFORD

Development of high throughput genetic testing for cerebellar ataxias
The Churchill Hospital
Department of Clinical Genetics

BELGIUM

ANTWERPEN
ANTWERPEN

FRANCE

ILE-DE-FRANCE
PARIS

Funded by an IRDiRC memberNeuromics: Integrated European -omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases - FR
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

GERMANY

Baden-Württemberg
TÜBINGEN

Funded by an IRDiRC memberNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Institut für Medizinische Genetik und angewandte Genomik

GERMANY

Nordrhein-Westfalen
BONN

GERMANY

Nordrhein-Westfalen
KÖLN

Funded by an IRDiRC memberNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases -DE-
Institut für Humangenetik am Universitätsklinikum Köln
Institut für Humangenetik

ITALY

LOMBARDIA
MILANO

Funded by an IRDiRC memberNEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases - IT
Università degli Studi di Milano - Scienze Farmacologiche e Biomolecolari
Laboratorio di Biologia delle Cellule Staminali

NETHERLANDS

Zuid-Holland
LEIDEN

UNITED STATES

Arizona
PHOENIX

Funded by an IRDiRC memberThe etiology of inherited neurological diseases
Phoenix Children's Hospital
Barrow Neurological Institute

UNITED KINGDOM

Lothian
EDINBURGH

Genetic disorders of human brain development
Western General Hospital
MRC Human Genetics Unit

UNITED KINGDOM

Oxfordshire
OXFORD

Clinical and Genetic Analysis of Ataxias and Related Disorders of Cerebellar Function
The Churchill Hospital
Department of Clinical Genetics

GERMANY

Bayern
MÜNCHEN

Funded by an IRDiRC memberRHAPSODY - Research to Assess Policies and Strategies for Dementia in the Young
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für Psychiatrie und Psychotherapie

ITALY

CAMPANIA
NAPOLI

Funded by an IRDiRC memberTelethon Undiagnosed Disease Program - Revised Proposal
Azienda Ospedaliera Universitaria - Seconda Università degli Studi di Napoli
Laboratorio di Genetica Medica

Multicentric Research projects